Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset - HMS LINCS Database

Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>

Cell	Small Molecule	Small Mol Concentration (uM)	Primary Target	Pathway	Mean Normalized Growth Rate Inhibition Value	Increased Fraction Dead
BT-20	A-1210477	0.0031623	Mcl-1	Misc	0.9994	-0.00302
BT-20	A-1210477	0.01	Mcl-1	Misc	1.0461	0.00227
BT-20	A-1210477	0.31623	Mcl-1	Misc	1.0544	-0.00191
BT-20	A-1210477	1.0	Mcl-1	Misc	1.0474	-0.00138
BT-20	A-1210477	10.0	Mcl-1	Misc	0.8209	0.04589
BT-20	Olaparib	0.001	PARP	Misc	1.0265	-0.00519
BT-20	Olaparib	0.31623	PARP	Misc	0.9400	0.00840
BT-20	Olaparib	1.0	PARP	Misc	0.9125	0.00565
BT-20	Olaparib	10.0	PARP	Misc	0.6064	0.04246
BT-20	Bleomycin	0.0010833	Radiation	Misc	0.9824	0.00530
BT-20	Bleomycin	0.031667	Radiation	Misc	0.9548	0.00025
BT-20	Bleomycin	0.1	Radiation	Misc	0.8145	0.02731
BT-20	Bleomycin	1.0	Radiation	Misc	0.3200	0.15033
BT-20	Bleomycin	3.1623	Radiation	Misc	-0.0603	0.30083
BT-20	Ipatasertib	0.01	AKT	PI3K/mTOR	0.9717	-0.00176
BT-20	Ipatasertib	0.031623	AKT	PI3K/mTOR	0.9656	0.00133
BT-20	Ipatasertib	0.31623	AKT	PI3K/mTOR	0.5886	0.02673
BT-20	Ipatasertib	1.0	AKT	PI3K/mTOR	0.4168	0.05632
BT-20	Alpelisib	0.001	PI3Ka	PI3K/mTOR	1.0513	0.00412
BT-20	Alpelisib	0.0031623	PI3Ka	PI3K/mTOR	1.0511	0.01061
BT-20	Alpelisib	0.031623	PI3Ka	PI3K/mTOR	0.9920	0.01246
BT-20	Alpelisib	0.1	PI3Ka	PI3K/mTOR	0.9578	0.00889
BT-20	Taselisib	0.0031623	PI3Ka, g, d	PI3K/mTOR	0.8758	0.02377
BT-20	Everolimus	10.0	mTOR1	PI3K/mTOR	0.3900	0.07549
BT-20	Everolimus	3.1623	mTOR1	PI3K/mTOR	0.4209	0.06403